United Therapeutics Corporation Selling, General and Administrative Expense
United Therapeutics Corporation (UTHR) reported Selling, General and Administrative Expense of $206.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-05
- United Therapeutics Corporation selling, general and administrative expense for the quarter ending 2026-06-30 was $206.70M, a 2.73% decline year-over-year.
- United Therapeutics Corporation selling, general and administrative expense for the quarter ending 2026-03-31 was $184.10M, a 8.23% increase year-over-year.
- United Therapeutics Corporation selling, general and administrative expense for the quarter ending 2025-12-31 was $190.60M, a 13.12% increase year-over-year.
- United Therapeutics Corporation selling, general and administrative expense for the quarter ending 2025-09-30 was $182.60M, a 16.70% decline year-over-year.
- United Therapeutics Corporation selling, general and administrative expense for fiscal 2025 was $755.80M, a 6.50% increase from fiscal 2024.
- United Therapeutics Corporation selling, general and administrative expense for fiscal 2024 was $709.70M, a 48.75% increase from fiscal 2023.
- United Therapeutics Corporation selling, general and administrative expense for fiscal 2023 was $477.10M, a 1.04% decline from fiscal 2022.
- United Therapeutics Corporation selling, general and administrative expense for fiscal 2022 was $482.10M, a 3.23% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $206.70M 10-Q · filed 2026-08-05 | $390.80M 10-Q · filed 2026-08-05 | $581.40M derived: sum of 3 quarters · filed 2026-08-05 | $764.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $184.10M 10-Q · filed 2026-05-06 | $374.70M derived: sum of 2 quarters · filed 2026-05-06 | $557.30M derived: sum of 3 quarters · filed 2026-05-06 | $769.80M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $190.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $373.20M derived: sum of 2 quarters · filed 2026-02-25 | $585.70M derived: sum of 3 quarters · filed 2026-08-05 | $755.80M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $182.60M 10-Q · filed 2025-10-29 | $395.10M derived: sum of 2 quarters · filed 2026-08-05 | $565.20M 10-Q · filed 2025-10-29 | $733.70M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $212.50M 10-Q · filed 2026-08-05 | $382.60M 10-Q · filed 2026-08-05 | $551.10M derived: sum of 3 quarters · filed 2026-08-05 | $770.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $170.10M 10-Q · filed 2026-05-06 | $338.60M derived: sum of 2 quarters · filed 2026-05-06 | $557.80M derived: sum of 3 quarters · filed 2026-05-06 | $735.40M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $168.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $387.70M derived: sum of 2 quarters · filed 2026-02-25 | $565.30M derived: sum of 3 quarters · filed 2026-02-25 | $709.70M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $219.20M 10-Q · filed 2025-10-29 | $396.80M derived: sum of 2 quarters · filed 2025-10-29 | $541.20M 10-Q · filed 2025-10-29 | $673.40M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $177.60M 10-Q · filed 2025-07-30 | $322.00M 10-Q · filed 2025-07-30 | $454.20M derived: sum of 3 quarters · filed 2026-02-25 | $581.80M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $144.40M 10-Q · filed 2025-04-30 | $276.60M derived: sum of 2 quarters · filed 2026-02-25 | $404.20M derived: sum of 3 quarters · filed 2026-02-25 | $534.20M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $132.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $259.80M derived: sum of 2 quarters · filed 2026-02-25 | $389.80M derived: sum of 3 quarters · filed 2026-02-25 | $477.10M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $127.60M 10-Q · filed 2024-10-30 | $257.60M derived: sum of 2 quarters · filed 2024-10-30 | $344.90M 10-Q · filed 2024-10-30 | $508.10M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $130.00M 10-Q · filed 2024-07-31 | $217.30M 10-Q · filed 2024-07-31 | $380.50M derived: sum of 3 quarters · filed 2025-02-26 | $478.90M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $87.30M 10-Q · filed 2024-05-01 | $250.50M derived: sum of 2 quarters · filed 2025-02-26 | $348.90M derived: sum of 3 quarters · filed 2025-02-26 | $490.40M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $163.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $261.60M derived: sum of 2 quarters · filed 2025-02-26 | $403.10M derived: sum of 3 quarters · filed 2025-02-26 | $482.10M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $98.40M 10-Q · filed 2023-11-01 | $239.90M derived: sum of 2 quarters · filed 2023-11-01 | $318.90M 10-Q · filed 2023-11-01 | $446.80M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $141.50M 10-Q · filed 2023-08-02 | $220.50M 10-Q · filed 2023-08-02 | $348.40M derived: sum of 3 quarters · filed 2024-02-21 | $457.50M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $79.00M 10-Q · filed 2023-05-03 | $206.90M derived: sum of 2 quarters · filed 2024-02-21 | $316.00M derived: sum of 3 quarters · filed 2024-02-21 | $428.80M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $127.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $237.00M derived: sum of 2 quarters · filed 2024-02-21 | $349.80M derived: sum of 3 quarters · filed 2024-02-21 | $467.00M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $109.10M 10-Q · filed 2022-11-02 | $221.90M derived: sum of 2 quarters · filed 2022-11-02 | $339.10M 10-Q · filed 2022-11-02 | |||||
| 2021-06-30 | $112.80M 10-Q · filed 2022-08-03 | $230.00M 10-Q · filed 2022-08-03 | ||||||
| 2018-12-31 | $265.80M 10-K · filed 2019-02-27 | |||||||
| 2017-12-31 | $159.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $206.30M derived: sum of 2 quarters · filed 2019-02-27 | $273.70M derived: sum of 3 quarters · filed 2019-02-27 | $330.10M 10-K · filed 2019-02-27 | ||||
| 2017-09-30 | $47.20M 10-Q · filed 2017-10-25 | $114.60M derived: sum of 2 quarters · filed 2017-10-25 | $171.00M 10-Q · filed 2017-10-25 | $310.50M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $67.40M 10-Q · filed 2017-07-27 | $123.80M 10-Q · filed 2017-07-27 | $263.30M derived: sum of 3 quarters · filed 2019-02-27 | $363.40M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $56.40M 10-Q · filed 2017-04-26 | $195.90M derived: sum of 2 quarters · filed 2019-02-27 | $296.00M derived: sum of 3 quarters · filed 2019-02-27 | $368.20M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $139.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $239.60M derived: sum of 2 quarters · filed 2019-02-27 | $311.80M derived: sum of 3 quarters · filed 2019-02-27 | $316.80M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $100.10M 10-Q · filed 2017-10-25 | $172.30M derived: sum of 2 quarters · filed 2017-10-25 | $177.30M 10-Q · filed 2017-10-25 | $326.00M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | $72.20M 10-Q · filed 2017-07-27 | $77.20M 10-Q · filed 2017-07-27 | $225.90M derived: sum of 3 quarters · filed 2018-02-21 | $208.60M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | $5.00M 10-Q · filed 2017-04-26 | $153.70M derived: sum of 2 quarters · filed 2018-02-21 | $136.40M derived: sum of 3 quarters · filed 2018-02-21 | $246.40M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | $148.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $131.40M derived: sum of 2 quarters · filed 2018-02-21 | $241.40M derived: sum of 3 quarters · filed 2018-02-21 | $452.70M 10-K · filed 2018-02-21 | $452.61M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | -$17.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $92.70M derived: sum of 2 quarters · filed 2016-10-27 | $304.00M 10-Q · filed 2016-10-27 | $304.05M 10-Q · filed 2015-10-27 | $384.55M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-06-30 | $110.00M 10-Q · filed 2016-07-28 | $109.99M 10-Q · filed 2015-07-28 | $321.30M 10-Q · filed 2016-07-28 | $321.33M 10-Q · filed 2015-07-28 | $401.85M derived: sum of 3 quarters · filed 2017-02-22 | $604.35M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2015-03-31 | $211.30M 10-Q · filed 2016-04-28 | $211.34M 10-Q · filed 2015-04-28 | $291.85M derived: sum of 2 quarters · filed 2017-02-22 | $494.35M derived: sum of 3 quarters · filed 2017-02-22 | $562.38M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | $80.55M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $283.05M derived: sum of 2 quarters · filed 2017-02-22 | $351.08M derived: sum of 3 quarters · filed 2017-02-22 | $381.30M 10-K · filed 2017-02-22 | $381.29M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $202.51M 10-Q · filed 2015-10-27 | $270.54M derived: sum of 2 quarters · filed 2015-10-27 | $300.75M 10-Q · filed 2015-10-27 | $457.93M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $68.03M 10-Q · filed 2015-07-28 | $98.25M 10-Q · filed 2015-07-28 | $255.42M derived: sum of 3 quarters · filed 2016-02-25 | $349.54M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $30.21M 10-Q · filed 2015-04-28 | $187.39M derived: sum of 2 quarters · filed 2016-02-25 | $281.50M derived: sum of 3 quarters · filed 2016-02-25 | $352.87M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $157.18M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $251.29M derived: sum of 2 quarters · filed 2016-02-25 | $322.65M derived: sum of 3 quarters · filed 2016-02-25 | $394.01M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $94.11M 10-Q · filed 2014-10-28 | $165.48M derived: sum of 2 quarters · filed 2014-10-28 | $236.83M 10-Q · filed 2014-10-28 | $276.90M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $71.36M 10-Q · filed 2014-07-29 | $142.72M 10-Q · filed 2014-07-29 | $182.79M derived: sum of 3 quarters · filed 2015-02-24 | $251.42M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $71.36M 10-Q · filed 2014-04-29 | $111.43M derived: sum of 2 quarters · filed 2015-02-24 | $180.06M derived: sum of 3 quarters · filed 2015-02-24 | $233.31M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $40.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $108.70M derived: sum of 2 quarters · filed 2015-02-24 | $161.96M derived: sum of 3 quarters · filed 2015-02-24 | $201.75M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $68.63M 10-Q · filed 2013-10-29 | $121.88M derived: sum of 2 quarters · filed 2013-10-29 | $161.67M 10-Q · filed 2013-10-29 | $219.38M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $53.26M 10-Q · filed 2013-07-25 | $93.05M 10-Q · filed 2013-07-25 | $150.75M derived: sum of 3 quarters · filed 2014-02-25 | $167.41M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $39.79M 10-Q · filed 2013-04-25 | $97.50M derived: sum of 2 quarters · filed 2014-02-25 | $114.15M derived: sum of 3 quarters · filed 2014-02-25 | $138.01M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $57.71M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $74.36M derived: sum of 2 quarters · filed 2014-02-25 | $98.22M derived: sum of 3 quarters · filed 2014-02-25 | $156.48M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $16.66M 10-Q · filed 2012-11-01 | $40.51M derived: sum of 2 quarters · filed 2012-11-01 | $98.78M 10-Q · filed 2012-11-01 | $166.68M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $23.86M 10-Q · filed 2012-07-26 | $82.12M 10-Q · filed 2012-07-26 | $150.03M derived: sum of 3 quarters · filed 2013-02-26 | $195.62M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $58.26M 10-Q · filed 2012-04-26 | $59.23M 10-Q · filed 2011-04-28 | $126.17M derived: sum of 2 quarters · filed 2013-02-26 | $171.76M derived: sum of 3 quarters · filed 2013-02-26 | $201.42M derived: sum of 4 quarters · filed 2013-02-26 | |||
| 2010-12-31 | $67.91M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $113.50M derived: sum of 2 quarters · filed 2013-02-26 | $143.15M derived: sum of 3 quarters · filed 2013-02-26 | $188.61M 10-K · filed 2013-02-26 | $199.60M 10-K · filed 2011-02-24 | |||
| 2010-09-30 | $45.59M 10-Q · filed 2011-10-27 | $46.69M 10-Q · filed 2010-10-28 | $75.25M derived: sum of 2 quarters · filed 2011-10-27 | $120.70M 10-Q · filed 2011-10-27 | $124.60M 10-Q · filed 2010-10-28 | $174.26M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-06-30 | $29.65M 10-Q · filed 2011-07-28 | $31.04M 10-Q · filed 2010-07-28 | $75.11M 10-Q · filed 2011-07-28 | $77.91M 10-Q · filed 2010-07-28 | $128.66M derived: sum of 3 quarters · filed 2012-02-28 | $169.84M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-03-31 | $46.88M 10-Q · filed 2011-04-28 | $99.01M derived: sum of 2 quarters · filed 2012-02-28 | $140.18M derived: sum of 3 quarters · filed 2012-02-28 | $189.55M derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2009-12-31 | $52.13M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $93.31M derived: sum of 2 quarters · filed 2012-02-28 | $142.68M derived: sum of 3 quarters · filed 2012-02-28 | $171.89M 10-K · filed 2012-02-28 | $176.34M 10-K · filed 2011-02-24 | |||
| 2009-09-30 | $41.17M 10-Q · filed 2010-10-28 | $90.54M derived: sum of 2 quarters · filed 2010-10-28 | $119.76M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $49.37M 10-Q · filed 2010-07-28 | $78.59M 10-Q · filed 2010-07-28 | ||||||
| 2008-12-31 | $94.31M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |